AllPennyStocks.com These Two Biotech Stocks Recorded Fresh Milestones Today – What’s Driving Today’s Gains?
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

These Two Biotech Stocks Recorded Fresh Milestones Today – What’s Driving Today’s Gains?

Both Amgen and Repligen saw price target hikes after better-than-expected Q2 results and potential gains from Moderna’s successful Phase 3 trial for melanoma therapy, respectively.

Other Penny Stock Movers

A $1 Billion Crypto Deal Sends This Microcap Surging
Chilean Gold Developer Gains 15% on Final Permit Clearance
Chile Copper Explorer Gains 19% on 795m Porphyry Hit
Most Popular
{{ index + 1 }}


Back to Top